Classic Studies on the Interaction of Cocaine and the Dopamine Transporter

키워드

참고문헌 (152)

1. Mohr E., "Late cognitive changes in Parkinson's disease with an emphasis on dementia", Adv Neurol, 65, pp.97~113 (1995)
2. Han DD., "Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs", BMC Pharmacol, 6, pp.6~ (2006)
3. Reith ME., "Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior", Biochem Pharmacol, 35, pp.1123~1129 (1986)
4. cocaine binding sites in caudate-putamen, "J Pharmacol Exp Ther", 1989, 131~141
5. Rothman RB., "Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin", Synapse, 39, pp.32~41 (2001)
6. Wang Z., "Effects of cocaine on monoamine uptake as measured ex vivo", Neurosci Lett, 413, pp.191~195 (2007)
7. Ritz MC., "Cocaine receptors on dopamine transporters are related to selfadministration of cocaine", Science, 237, pp.1219~1223 (1987)
8. Jones SR., "Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens", J Pharmacol Exp Ther, 274, pp.396~403 (1995)
9. Davis M., "Cocaine : excitatory effects on sensorimotor reactivity measured with acoustic startle", Psychopharmacology(Berl), 86, pp.31~36 (1985)
10. Kuhar MJ., "The dopamine hypothesis of the reinforcing properties of cocaine", Trends Neurosci, 14, pp.299~302 (1991)
11. Barr GA., "Conditioned place preference from ventral tegmental injection of morphine in neonatal rats", Brain Res Dev Brain Res, 66, pp.133~136 (1992)
12. Fiorino DF., "Electrical stimulation of reward sites in the ventral tegmental area increases dopamine transmission in the nucleus accumbens of the rat", Behav Brain Res, 55, pp.131~141 (1993)
13. Ikemoto S., "Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area", J Neurosci, 22, pp.9895~9904 (2002)
14. Childress AR., "Limbic activation during cueinduced cocaine craving", Am J Psychiatry, 156, pp.11~18 (1999)
15. Hall FS., "Molecular mechanisms underlying the rewarding effects of cocaine", Ann N Y Acad Sci, 1025, pp.47~56 (2004)
16. Hastrup H., "Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment", Proc Natl Acad Sci U S A, 98, pp.10055~10060 (2001)
17. Torres GE., "Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter", J Biol Chem, 278, pp.2731~2739 (2003)
18. Hastrup H., "The human dopamine transporter forms a tetramer in the plasma membrane : cross-linking of a cysteine in the fourth transmembrane segment is sensitive to cocaine analogs", J Biol Chem, 278, pp.45045~45048 (2003)
19. Giros B., "Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters", J Biol Chem, 269, pp.15985~15988 (1994)
20. Buck KJ., "Chimeric dopamine-norepinephrine transporters delineate structural domains influencing selectivity for catecholamines and 1-methyl-4-phenylpyridinium", Proc Natl Acad Sci U S A, 91, pp.12584~12588 (1994)
21. Buck KJ., "Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants", Mol Pharmacol, 48, pp.1030~1037 (1995)
22. Beuming T., "The binding sites for cocaine and dopamine in the dopamine transporter overlap", Nat Neurosci, 11, pp.780~789 (2008)
23. Chen N., "Structure and function of the dopamine transporter", Eur J Pharmacol, 405, pp.329~339 (2000)
24. Giros B., "Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter", Mol Pharmacol, 42, pp.383~390 (1992)
25. Javitch JA., "Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine : uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity", Proc Natl Acad Sci U S A, 82, pp.2173~2177 (1985)
26. Chiba K., "Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes", Biochem Biophys Res Commun, 128, pp.1228~1232 (1985)
27. Willoughby J., "1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes", J Neurochem, 52, pp.627~631 (1989)
28. Tipton KF., "Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds", J Neurochem, 61, pp.1191~1206 (1993)
29. Storch A., "Dopamine transporter : involvement in selective dopaminergic neurotoxicity and degeneration", J Neural Transm, 111, pp.1267~1286 (2004)
30. Di Matteo V., "7-nitroindazole protects striatal dopaminergic neurons against MPP+-induced degeneration : an in vivo microdialysis study", Ann N Y Acad Sci, 1089, pp.462~471 (2006)
31. Gainetdinov RR., "Dopamine transporter is required for in vivo MPTP neurotoxicity : evidence from mice lacking the transporter", J Neurochem, 69, pp.1322~1325 (1997)
32. Mayer RA., "Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine by inhibitors of 3, 4-dihydroxyphenylethylamine transport", J Neurochem, 47, pp.1073~1079 (1986)
33. Lin Z., "Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression", FASEB J, 14, pp.715~728 (2000)
34. Dar DE., "Dopamine uptake and cocaine binding mechanisms : the involvement of charged amino acids from the transmembrane domains of the human dopamine transporter", Eur J Pharmacol, 538, pp.43~47 (2006)
35. Kitayama S., "Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding", Proc Natl Acad Sci U S A, 89, pp.7782~7785 (1992)
36. Kitayama S., "Dopamine transporter mutants selectively enhance MPP+ transport", Synapse, 15, pp.58~62 (1993)
37. Pifl C., "Induction by low Na＋ or Cl− of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters", Br J Pharmacol, 121, pp.205~212 (1997)
38. Uhl GR., "Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism", Mov Disord, 18(Suppl 7), pp.S71~S80 (2003)
39. Copeland BJ., "Protein kinase C activators decrease dopamine uptake into striatal synaptosomes", J Pharmacol Exp Ther, 277, pp.1527~1532 (1996)
40. Huff RA., "Phorbol esters increase dopamine transporter phosphorylation and decrease transport Vmax", J Neurochem, 68, pp.225~232 (1997)
41. Vaughan RA., "Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes", J Biol Chem, 272, pp.15541~15546 (1997)
42. Foster JD., "Dopamine transporters are phosphorylated on N-terminal serines in rat striatum", J Biol Chem, 277, pp.25178~25186 (2002)
43. Lin Z., "Phosphatidylinositol 3-kinase, protein kinase C, and MEK1", 2 kinase regulation of dopamine transporters(DAT)require N-terminal DAT phosphoacceptor sites, 2003, pp.278, 20162~20170
44. Corey JL., "Protein kinase C modulates the activity of a cloned gamma-aminobutyric acid transporter expressed in Xenopus oocytes via regulated subcellular redistribution of the transporter", J Biol Chem, 269, pp.14759~14767 (1994)
45. Qian Y., "Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression", J Neurosci, 17, pp.45~57 (1997)
46. Ramamoorthy S., "Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants", Science, 285, pp.763~766 (1999)
47. Melikian HE., "Membrane trafficking regulates the activity of the human dopamine transporter", J Neurosci, 19, pp.7699~7710 (1999)
48. Daniels GM., "Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters", J Biol Chem, 274, pp.35794~35801 (1999)
49. Doolen S., "Conventional protein kinase C isoforms regulate human dopamine transporter activity in Xenopus oocytes", FEBS Lett, 516, pp.187~190 (2002)
50. Torres GE., "The dopamine transporter proteome", J Neurochem, 97(Suppl 1), pp.3~10 (2006)
51. Volkow ND., "Methylphenidate and cocaine have a similar in vivo potency to block dopamine transporters in the human brain", Life Sci, 65, pp.PL7~PL12 (1999)
52. Rothman RB., "Studies of the biogenic amine transporters. 10. Characterization of a novel cocaine binding site in brain membranes prepared from dopamine transporter knockout mice", Synapse, 44, pp.94~105 (2002)
53. RTI-55 to dopamine and serotonin transporters in rat brain, "Synapse", 1992, 27~36
54. Carroll FI., "Isopropyl and phenyl esters of 3 beta-(4-substituted phenyl)tropan-2 beta-carboxylic acids. Potent and selective compounds for the dopamine transporter", J Med Chem, 35, pp.2497~2500 (1992)
55. RTI-55, "J Pharmacol Exp Ther", 1994, 296~309
56. RTI-55 : in vitro binding and autoradiographic characterization, "J Neurochem", 1994, 549~556
57. Rothman RB., "Monoamine transporters and psychostimulant drugs", Eur J Pharmacol, 479, pp.23~40 (2003)
58. tropane to the dopamine uptake carrier, "J Neurochem", 1993, 167~177
59. Chen N., "Mutation of Trp84 and Asp313 of the dopamine transporter reveals similar mode of binding interaction for GBR12909 and benztropine as opposed to cocaine", J Neurochem, 89, pp.853~864 (2004)
60. RTI 82 irreversible binding to transmembrane domain 6 of the dopamine transporter, "J Biol Chem", 2007, 8915~8925
61. Ravna AW., "Molecular model of the neural dopamine transporter", J Comput Aided Mol Des, 17, pp.367~382 (2003)
62. Volz TJ., "A comprehensive atlas of the topography of functional groups of the dopamine transporter", Synapse, 58, pp.72~94 (2005)
63. Surratt CK., "Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters", AAPS J, 7, pp.E739~E751 (2005)
64. Wang W., "Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter", Mol Pharmacol, 64, pp.430~439 (2003)
65. Chen N., "The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site-directed mutagenesis", J Neurochem, 77, pp.1116~1127 (2001)
66. Kimmel HL., "Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys", Pharmacol Biochem Behav, 86, pp.45~54 (2007)
67. Surratt CK., "Sodium-and chloride-dependent transporters in brain, kidney, and gut : lessons from complementary DNA cloning and structure-function studies", Curr Opin Nephrol Hypertens, 2, pp.744~760 (1993)
68. Loland CJ., "Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding", J Biol Chem, 279, pp.3228~3238 (2004)
69. Lin Z., "Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism", Mol Pharmacol, 61, pp.885~891 (2002)
70. Kitayama S., "Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells", Ann N Y Acad Sci, 801, pp.388~393 (1996)
71. Chen JG., "The third transmembrane domain of the serotonin transporter contains residues associated with substrate and cocaine binding", J Biol Chem, 272, pp.28321~28327 (1997)
72. Mitsuhata C., "Tyrosine-533 of rat dopamine transporter : involvement in interactions with 1-methyl-4-phenylpyridinium and cocaine", Brain Res Mol Brain Res, 56, pp.84~88 (1998)
73. Lin Z., "Dopamine transporter : transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition", Mol Pharmacol, 56, pp.434~447 (1999)
74. Lee SH., "Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter", Mol Pharmacol, 57, pp.883~889 (2000)
75. Rocha BA., "Cocaine self-administration in dopaminetransporter knockout mice", Nat Neurosci, 1, pp.132~137 (1998)
76. Carboni E., "Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene", J Neurosci, 21, pp.RC141,1~RC141,4 (2001)
77. Sora I., "Molecular mechanisms of cocaine reward : combined dopamine and serotonin transporter knockouts eliminate cocaine place preference", Proc Natl Acad Sci U S A, 98, pp.5300~5305 (2001)
78. Mateo Y., "Role of serotonin in cocaine effects in mice with reduced dopamine transporter function", Proc Natl Acad Sci U S A, 101, pp.372~377 (2004)
79. Medvedev IO., "Characterization of conditioned place preference to cocaine in congenic dopamine transporter knockout female mice", Psychopharmacology(Berl), 180, pp.408~413 (2005)
80. Jones SR., "Loss of autoreceptor functions in mice lacking the dopamine transporter", Nat Neurosci, 2, pp.649~655 (1999)
81. Giros B., "Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter", Nature, 379, pp.606~612 (1996)
82. Caine SB., "Cocaine abuse : hard knocks for the dopamine hypothesis?", Nat Neurosci, 1, pp.90~92 (1998)
83. Uhl G., "Cocaine, reward, movement and monoamine transporters", Mol Psychiatry, 7, pp.21~26 (2002)
84. Rocha BA., "Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice", Eur J Pharmacol, 479, pp.107~115 (2003)
85. Chen R., "Abolished cocaine reward in mice with a cocaineinsensitive dopamine transporter", Proc Natl Acad Sci U S A, 103, pp.9333~9338 (2006)
86. Wu Q., "Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission", J Neurosci, 21, pp.6338~6347 (2001)
87. Greco PG., "In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry", Eur J Pharmacol, 479, pp.117~125 (2003)
88. mazindol-labelling of dopamine transporter in rat nucleus accumbens, "Eur J Pharmacol", 1991, 141~144
89. Farfel GM., "Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey", Brain Res, 578, pp.235~243 (1992)
90. Byrnes JJ., "Prenatal cocaine exposure : decreased sensitization to cocaine and decreased striatal dopamine transporter binding in offspring", Neuropharmacology, 32, pp.721~723 (1993)
91. Pilotte NS., "Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats", J Pharmacol Exp Ther, 269, pp.963~969 (1994)
92. Wilson JM., "Heterogeneous subregional binding patterns of 3H-WIN 35, 428 and 3H-GBR 12, 935 are differentially regulated by chronic cocaine self-administration", J Neurosci, 14, pp.2966~2979 (1994)
93. mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine, "J Pharmacol Exp Ther", 1996, 330~337
94. Pilotte NS., "Cocaine withdrawal reduces dopamine transporter binding in the shell of the nucleus accumbens", Synapse, 22, pp.87~92 (1996)
95. Alburges ME., "Alterations in the dopaminergic receptor system after chronic administration of cocaine", Synapse, 14, pp.314~323 (1993)
96. WIN 35428 binding sites in human striatum, "Brain Res", 1993, 17~25
97. Staley JK., "High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims", J Pharmacol Exp Ther, 271, pp.1678~1685 (1994)
98. Hitri A., "Effect of cocaine on dopamine transporter receptors depends on routes of chronic cocaine administration", Neuropsychopharmacology, 14, pp.205~210 (1996)
99. Little KY., "Brain dopamine transporter messenger RNA and binding sites in cocaine users : a postmortem study", Arch Gen Psychiatry, 55, pp.793~799 (1998)
100. beta-CIT SPECT, "Am J Psychiatry", 1998, 832~834
101. Little KY., "Striatal dopaminergic abnormalities in human cocaine users", Am J Psychiatry, 156, pp.238~245 (1999)
102. GBR-12935 binding after chronic treatment with dopamine active drugs, "Psychopharmacology(Berl)", 1990, 291~294
103. Kula NS., "Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine", Neuropharmacology, 30, pp.89~92 (1991)
104. Benmansour S., "Lack of effect of high-dose cocaine on monoamine uptake sites in rat brain measured by quantitative autoradiography", Psychopharmacology(Berl), 106, pp.459~462 (1992)
105. Cass WA., "Reduced clearance of exogenous dopamine in rat nucleus accumbens, but not in dorsal striatum, following cocaine challenge in rats withdrawn from repeated cocaine administration", J Neurochem, 61, pp.273~283 (1993)
106. Wilson JM., "Amygdala dopamine levels are markedly elevated after self-but not passive-administration of cocaine", Brain Res, 668, pp.39~45 (1994)
107. Wilson JM., "Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users", Ann Neurol, 40, pp.428~439 (1996)
108. Kunko PM., "Chronic administration of the selective dopamine uptake inhibitor GBR 12, 909, but not cocaine, produces marked decreases in dopamine transporter density", Naunyn Schmiedebergs Arch Pharmacol, 356, pp.562~569 (1997)
109. Letchworth SR., "Regulation of rat dopamine transporter mRNA and protein by chronic cocaine administration", J Neurochem, 73, pp.1982~1989 (1999)
110. Kimmel HL., "Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum", J Pharmacol Exp Ther, 304, pp.15~21 (2003)
111. Chen N., "Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells", J Neurochem, 101, pp.377~388 (2007)
112. Shippenberg TS., "Sensitization to the conditioned rewarding effects of morphine : pharmacology and temporal characteristics", Eur J Pharmacol, 299, pp.33~39 (1996)
113. Steketee JD., "Cortical mechanisms of cocaine sensitization", Crit Rev Neurobiol, 17, pp.69~86 (2005)
114. Zahniser NR., "Sensitization to cocaine in the nigrostriatal dopamine system", NIDA Res Monogr, 88, pp.55~77 (1988)
115. Ujike H., "Supersensitivity of sigma receptors after repeated administration of cocaine", Life Sci, 51, pp.PL31~PL36 (1992)
116. Itzhak Y., "Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex", J Pharmacol Exp Ther, 262, pp.464~470 (1992)
117. Kim DS., "Dopamine-dependent desensitization of dopaminergic signaling in the developing mouse striatum", J Neurosci, 22, pp.9841~9849 (2002)
118. Fang Y., "Cocaine upregulates the dopamine transporter in fetal rhesus monkey brain", J Neurosci, 19, pp.8966~8978 (1999)
119. Daws LC., "Cocaine increases dopamine uptake and cell surface expression of dopamine transporters", Biochem Biophys Res Commun, 290, pp.1545~1550 (2002)
120. Mash DC., "Dopamine transport function is elevated in cocaine users", J Neurochem, 81, pp.292~300 (2002)
121. Kahlig KM., "Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine", Eur J Pharmacol, 479, pp.153~158 (2003)
122. Cerruti C., "Reduction in dopamine transporter mRNA after cessation of repeated cocaine administration", Brain Res Mol Brain Res, 22, pp.132~138 (1994)
123. Leslie CA., "Effects of prenatal cocaine exposure upon postnatal development of neostriatal dopaminergic function", Synapse, 17, pp.210~215 (1994)
124. mazindol-labelled dopamine uptake sites in the rat striatum following prenatal cocaine exposure, "Brain Res", 1994, 345~348
125. Collins LM., "Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum", Synapse, 23, pp.335~343 (1996)
126. Tella SR., "Differential reinforcing effects of cocaine and GBR-12909 : biochemical evidence for divergent neuroadaptive changes in the mesolimbic dopaminergic system", J Neurosci, 16, pp.7416~7427 (1996)
127. Little KY., "Cocaine induction of dopamine transporter trafficking to the plasma membrane", Mol Pharmacol, 61, pp.436~445 (2002)
128. Zahniser NR., "Chronic and acute regulation of Na＋", Cl--dependent neurotransmitter transporters : drugs, substrates, presynaptic receptors, and signaling systems, 2001, pp.92, 21~55
129. Cowell RM., "Dopamine transporter antagonists block phorbol esterinduced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes", Eur J Pharmacol, 389, pp.59~65 (2000)
130. Torres GE., "Approaches to identify monoamine transporter interacting proteins", J Neurosci Methods, 143, pp.63~68 (2005)
131. Torres GE., "Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domaincontaining protein PICK1", Neuron, 30, pp.121~134 (2001)
132. Carneiro AM., "The multiple LIM domaincontaining adaptor protein Hic-5 synaptically colocalizes and interacts with the dopamine transporter", J Neurosci, 22, pp.7045~7054 (2002)
133. Lee KH., "Syntaxin 1A and receptor for activated C kinase interact with the N-terminal region of human dopamine transporter", Neurochem Res, 29, pp.1405~1409 (2004)
134. Dickinson SD., "Dopamine D2 receptordeficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum", J Neurochem, 72, pp.148~156 (1999)
135. Lee FJ., "Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor", EMBO J, 26, pp.2127~2136 (2007)
136. Torres GE., "Plasma membrane monoamine transporters : structure, regulation and function", Nat Rev Neurosci, 4, pp.13~25 (2003)
137. Cook EH Jr., "Association of attention-deficit disorder and the dopamine transporter gene", Am J Hum Genet, 56, pp.993~998 (1995)
138. Waldman ID., "Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children : heterogeneity owing to diagnostic subtype and severity", Am J Hum Genet, 63, pp.1767~1776 (1998)
139. Madras BK., "Dopamine transporter(DAT)inhibitors alleviate specific parkinsonian deficits in monkeys : association with DAT occupancy in vivo", J Pharmacol Exp Ther, 319, pp.570~585 (2006)
140. Rodriguiz RM., "Aberrant responses in social interaction of dopamine transporter knockout mice", Behav Brain Res, 148, pp.185~198 (2004)
141. Tillerson JL., "Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor", Behav Brain Res, 172, pp.97~105 (2006)
142. Kavelaars A., "Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene", J Neuroimmunol, 161, pp.162~168 (2005)
143. Wang GJ., "Cocaine abusers do not show loss of dopamine transporters with age", Life Sci, 61, pp.1059~1065 (1997)
144. Carroll FI., "Pharmacotherapies for treatment of cocaine abuse : preclinical aspects", J Med Chem, 42, pp.2721~2736 (1999)
145. Mead AN., "Intravenous cocaine induced-activity and behavioural sensitization in norepinephrine-, but not dopamine-transporter knockout mice", Eur J Neurosci, 16, pp.514~520 (2002)
146. Howell LL., "The dopamine transporter and cocaine medication development : drug self-administration in nonhuman primates", J Pharmacol Exp Ther, 298, pp.1~6 (2001)
147. Ginsburg BC., "Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys", Pharmacol Biochem Behav, 80, pp.481~491 (2005)
148. Lile JA., "Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food-and cocaine-maintained responding in rhesus monkeys", Psychopharmacology(Berl), 174, pp.246~253 (2004)
149. Gulley JM., "Individual differences in cocaine-induced locomotor activity in rats : behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter", Neuropsychopharmacology, 28, pp.2089~2101 (2003)
150. Briegleb SK., "Individual differences in cocaine-and amphetamineinduced activation of male Sprague-Dawley rats : contribution of the dopamine transporter", Neuropsychopharmacology, 29, pp.2168~2179 (2004)
151. Volkow ND., "Relationship between subjective effects of cocaine and dopamine transporter occupancy", Nature, 386, pp.827~830 (1997)
152. Venton BJ., "Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool", J Neurosci, 26, pp.3206~3209 (2006)

관련 논문AI추천